Beneficient 8-K filings

NASDAQ
Beneficient's Chief Executive Officer and Chairman, Brad Heppner, has resigned effective immediately following his refusal to cooperate with an Audit Committee inquiry into his relationship with a related entity and a dispute over potential disclosures.
NASDAQ
Beneficient has successfully closed a $1.91 million primary capital transaction by issuing Series B-8 Resettable Convertible Preferred Stock, expanding its alternative asset financing solutions.
NASDAQ
Beneficient announced that the Bankruptcy Court has approved the settlement agreement resolving all claims in the GWG Holdings, Inc. litigation against the company and its parties, subject to a 14-day appeal period and District Court approval.
NASDAQ
Beneficient announced the immediate termination of its previously disclosed Stock Purchase Agreement to acquire Mercantile Bank International Corp., with no additional liability incurred by Beneficient.
NASDAQ
Beneficient announced that its stockholders approved the election of seven directors and the ratification of Weaver and Tidwell, LLP as its independent registered public accounting firm at the 2025 annual meeting, which had been adjourned multiple times.
NASDAQ
Beneficient has closed a primary capital transaction, providing $233,333 to Cork & Vines Fund I, LP in exchange for shares of the company's Resettable Convertible Preferred Stock.
NASDAQ
Beneficient closed a $9.6 million primary capital transaction, issuing Series B-6 Resettable Convertible Preferred Stock in exchange for a limited partner interest in an investment fund.
NASDAQ
Beneficient announces a subscription agreement with Hatteras Master Fund and settles all claims in the GWG Litigation, resolving disputes without admitting fault and focusing on future growth.
NASDAQ
Beneficient announces the date for its 2025 annual meeting of stockholders and related deadlines for shareholder proposals and director nominations.
NASDAQ
Beneficient reports increased revenues and decreased operating expenses for Q3 2025, alongside announcing a proposed transaction to increase tangible book value and an international bank acquisition.
NASDAQ
Beneficient is providing an investor presentation to be used at the Sequire Investor Summit on January 22, 2025.
NASDAQ
Beneficient has received a notice from Nasdaq stating that its share price has fallen below the minimum required for continued listing.
NASDAQ
Beneficient closed a $1.36 million primary capital transaction, issuing Series B-5 Resettable Convertible Preferred Stock in exchange for a limited partner interest in an investment fund.
NASDAQ
Beneficient has entered into a master agreement to amend its subsidiary's governing documents, allowing public stockholders to share in liquidation priority and creating tangible book value.
NASDAQ
Beneficient has agreed to acquire Mercantile Bank International for $1.5 million in a mix of stock and cash, aiming to broaden its custody services and tap into new international markets.
NASDAQ
Beneficient has released an investor presentation to be used at the Emerging Growth Conference on December 4, 2024.
NASDAQ
Beneficient has received confirmation from Nasdaq that it has regained compliance with both the minimum stockholders' equity and audit committee requirements, allowing its securities to continue trading on the exchange.
NASDAQ
Beneficient appointed Karen Wendel to its board of directors and increased its permanent equity by $35 million through a redesignation of preferred shares, aiming to regain compliance with Nasdaq listing requirements.
NASDAQ
Beneficient announced its second consecutive profitable quarter as a public company, with increased revenues and a strengthened balance sheet.
NASDAQ
Beneficient is providing an investor presentation at the LD Micro Main Event XVII Conference on October 30, 2024.
NASDAQ
Beneficient terminated a forward purchase agreement with RiverNorth and increased its authorized Class A common stock shares to 5 billion.
NASDAQ
Beneficient reclassified approximately $126 million of temporary equity to permanent equity and appointed Patrick J. Donegan to its Board of Directors.
NASDAQ
Beneficient sold 150,000 shares of its Class A common stock to Cangany Capital Management, a firm controlled by a board member, in a private transaction.
NASDAQ
Beneficient has submitted a plan to Nasdaq to regain compliance with minimum equity requirements by reclassifying $125.5 million of temporary equity to permanent equity.
NASDAQ
Beneficient has raised $325,000 through the sale of Class A common stock to board members via private placements.
NASDAQ
Beneficient has amended its credit agreement to include an additional term loan of up to $1.675 million and to waive certain defaults.
NASDAQ
Beneficient released an investor presentation in connection with its participation at the Sidoti Micro-Cap Conference on August 15, 2024.
NASDAQ
Beneficient achieved its first profitable quarter as a public company in Q1 2025, driven by improved financial results and the launch of a new automated pricing system.
NASDAQ
Beneficient has entered into a securities purchase agreement for a private placement of up to $4 million in convertible debentures and warrants.
NASDAQ
A Texas court has vacated a $55.3 million arbitration award against Beneficient, a financial services company.